Cardinal Health (CAH) Financials: History & Chart

Cardinal Health, Inc. (CAH)CAHCardinal Health, Inc.

About Cardinal Health, Inc.

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

Dublin, OH

57,700 employees

www.cardinalhealth.com

Healthcare / Medical - Distribution

Sector: Healthcare
Industry: Medical - Distribution
CEO: Jason Hollar

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Revenue	250.55B	60.94B	65.44B	64.01B	60.16B	54.88B	55.26B	52.28B	59.71B
Cost of Goods Sold	241.32B	58.44B	63.23B	61.69B	57.96B	52.76B	53.32B	50.38B	57.85B
Gross Profit	9.23B	2.50B	2.21B	2.32B	2.20B	2.12B	1.94B	1.90B	1.85B
Gross Profit Margin	3.7%	4.1%	3.4%	3.6%	3.7%	3.9%	3.5%	3.6%	3.1%
Total Operating Expenses	6.92B	1.99B	1.50B	1.65B	1.77B	1.39B	1.39B	1.33B	1.45B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	5.99B	1.54B	1.50B	1.46B	1.48B	1.31B	1.31B	1.28B	1.24B
Operating Income (EBIT)	2.31B	509.00M	707.00M	668.00M	428.00M	730.00M	549.00M	568.00M	408.00M
Operating Margin	0.9%	0.8%	1.1%	1.0%	0.7%	1.3%	1.0%	1.1%	0.7%
Income Before Tax (EBT)	2.00B	392.00M	630.00M	598.00M	384.00M	665.00M	511.00M	541.00M	396.00M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	343.00M	101.00M	88.00M	80.00M	74.00M	74.00M	35.00M	32.00M	4.00M
Other Income/Expense	-308.00M	-117.00M	-77.00M	-70.00M	-44.00M	-65.00M	-38.00M	-27.00M	-12.00M
Net Income	1.56B	399.00M	471.00M	450.00M	239.00M	506.00M	400.00M	416.00M	236.00M
Income Tax Expense	456.00M	12.00M	159.00M	144.00M	141.00M	157.00M	110.00M	124.00M	162.00M
Net Profit Margin	0.6%	0.7%	0.7%	0.7%	0.4%	0.9%	0.7%	0.8%	0.4%
EBITDA	3.17B	757.00M	872.00M	901.00M	637.00M	937.00M	741.00M	750.00M	594.00M
EBITDA Margin	1.3%	1.2%	1.3%	1.4%	1.1%	1.7%	1.3%	1.4%	1.0%
Depreciation & Amortization	855.00M	248.00M	165.00M	233.00M	209.00M	207.00M	192.00M	182.00M	186.00M
EPS Basic	6.56	1.69	1.98	1.89	1.00	2.11	1.65	1.71	0.96
EPS Diluted	6.54	1.69	1.97	1.88	1.00	2.10	1.65	1.70	0.96
Shares Outstanding	235.00M	235.00M	236.00M	238.00M	239.00M	240.00M	242.00M	243.00M	244.00M
Diluted Shares Outstanding	236.00M	236.00M	237.00M	239.00M	240.00M	241.00M	243.00M	245.00M	245.00M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021	06/30/2020	06/30/2019	06/30/2018
Revenue	222.58B	226.83B	204.98B	181.33B	162.47B	152.92B	145.53B	136.81B
Cost of Goods Sold	214.41B	219.41B	198.10B	174.84B	155.69B	146.05B	138.70B	129.63B
Gross Profit	8.17B	7.41B	6.89B	6.48B	6.78B	6.87B	6.83B	7.18B
Gross Profit Margin	3.7%	3.3%	3.4%	3.6%	4.2%	4.5%	4.7%	5.2%
Total Operating Expenses	5.89B	6.17B	6.12B	7.09B	6.31B	10.97B	4.77B	7.05B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	5.38B	5.00B	4.80B	4.51B	4.53B	4.57B	4.48B	4.60B
Operating Income (EBIT)	2.27B	1.24B	752.00M	-607.00M	472.00M	-4.10B	2.06B	126.00M
Operating Margin	1.0%	0.5%	0.4%	-0.3%	0.3%	-2.7%	1.4%	0.1%
Income Before Tax (EBT)	2.10B	1.20B	663.00M	-784.00M	323.00M	-3.77B	1.75B	-228.00M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	215.00M	51.00M	84.00M	147.00M	180.00M	238.00M	294.00M	329.00M
Other Income/Expense	-174.00M	-42.00M	-89.00M	-177.00M	-149.00M	326.00M	-309.00M	-354.00M
Net Income	1.56B	852.00M	330.00M	-938.00M	611.00M	-3.69B	1.36B	256.00M
Income Tax Expense	532.00M	348.00M	332.00M	153.00M	-289.00M	-79.00M	386.00M	-487.00M
Net Profit Margin	0.7%	0.4%	0.2%	-0.5%	0.4%	-2.4%	0.9%	0.2%
EBITDA	3.06B	1.95B	1.44B	85.00M	1.25B	-3.19B	3.06B	1.16B
EBITDA Margin	1.4%	0.9%	0.7%	0.0%	0.8%	-2.1%	2.1%	0.8%
Depreciation & Amortization	790.00M	710.00M	692.00M	692.00M	783.00M	913.00M	1.00B	1.03B
EPS Basic	6.48	3.48	1.26	-3.34	2.09	-12.60	4.54	0.82
EPS Diluted	6.45	3.45	1.26	-3.34	2.08	-12.60	4.53	0.81
Shares Outstanding	241.00M	245.00M	261.00M	279.00M	292.00M	293.00M	300.00M	313.00M
Diluted Shares Outstanding	242.00M	247.00M	262.00M	279.00M	294.00M	293.00M	301.00M	315.00M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.